LON AGL opened at GBX 48.50 ($0.68) on Thursday. ANGLE has a 12 month low of GBX 32.27 ($0.45) and a 12 month high of GBX 80 ($1.12).
COPYRIGHT VIOLATION WARNING: “FinnCap Reaffirms Corporate Rating for ANGLE (AGL)” was originally published by Ticker Report and is the property of of Ticker Report. If you are viewing this piece on another publication, it was stolen and republished in violation of international copyright and trademark law. The original version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3339901/finncap-reaffirms-corporate-rating-for-angle-agl.html.
ANGLE plc is a holding company. The Company’s principal activity is undertaken in relation to the commercialization of its Parsortix cell separation system, with deployment in non-invasive cancer diagnostics. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health.
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.